Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 54:1303-1308, doi:10.1016/j.jacc.2009.07.013
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Teo, K. K.
PubMed
Right arrow Articles by Teo, K. K.
Related Collections
Right arrowRelated Article

CLINICAL RESEARCH: CORONARY ARTERY DISEASE

Optimal Medical Therapy With or Without Percutaneous Coronary Intervention in Older Patients With Stable Coronary Disease

A Pre-Specified Subset Analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) Trial

Koon K. Teo, MB, BCh, PhD*, Steven P. Sedlis, MD{dagger}, William E. Boden, MD{ddagger},*, Robert A. O'Rourke, MD§, David J. Maron, MD||, Pamela M. Hartigan, PhD, Marcin Dada, MD#, Vipul Gupta, MBBS, MPH{ddagger}, John A. Spertus, MD, MPH**, William J. Kostuk, MD{dagger}{dagger}, Daniel S. Berman, MD{ddagger}{ddagger}, Leslee J. Shaw, PhD§§, Bernard R. Chaitman, MD||||, G.B. John Mancini, MD¶¶, William S. Weintraub, MD## COURAGE Trial Investigators

* McMaster University Medical Center, Hamilton, Ontario, Canada
{dagger} Veterans Affairs (VA) New York Harbor Health Care System and New York University School of Medicine, New York, New York
{ddagger} VA Western New York Health Care System, Buffalo General Hospital, and the University at Buffalo, Buffalo, New York
§ VA South Texas Health Care System, San Antonio, Texas
|| Vanderbilt University Medical Center, Nashville, Tennessee
VA Cooperative Studies Program Coordinating Center and VA Connecticut Health Care System, West Haven, Connecticut
# Hartford Hospital, Hartford, Connecticut
** Mid America Heart Institute, Kansas City, Missouri
{dagger}{dagger} London Health Sciences Centre, London, Ontario, Canada
{ddagger}{ddagger} Cedars-Sinai Medical Center, Los Angeles, California
§§ Emory University School of Medicine, Atlanta, Georgia
|||| St. Louis University, St. Louis, Missouri
¶¶ University of British Columbia, Vancouver, British Columbia, Canada
## Christiana Care Health System, Newark, Delaware

Manuscript received April 24, 2009; revised manuscript received July 8, 2009, accepted July 13, 2009.

* Reprint requests and correspondence: Dr. William E. Boden, Division of Cardiology, Buffalo General Hospital, 100 High Street, Buffalo, New York 14203 (Email: wboden{at}kaleidahealth.org).

Objectives: Our aim was to access clinical effectiveness of percutaneous coronary intervention (PCI) when added to optimal medical therapy (OMT) in older patients with stable coronary artery disease (CAD).

Background: While older patients with CAD are at increased risk for cardiac events compared with younger patients, it is unclear whether PCI may mitigate this risk more effectively than OMT alone or, alternatively, may be associated with more complications.

Methods: We conducted a pre-specified analysis of outcomes in stable CAD patients stratified by age and randomized to PCI + OMT or OMT alone in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.

Results: A total of 1,381 patients (60%) were <65 years of age (mean 56 ± 6 years) and 904 patients (40%) were ≥65 years of age (mean 72 ± 5 years). Achieved treatment targets for blood pressure, low-density lipoprotein cholesterol, adherence to diet and exercise, and angina-free status did not differ by age or treatment assignment. Among older patients, there was a 2- to 3-fold higher death rate, but similar rates of myocardial infarction, stroke, and major cardiac events compared with younger patients. The addition of PCI to OMT did not improve or worsen clinical outcomes in patients ≥65 years of age during a median 4.6 year follow-up.

Conclusions: These data support adherence to American College of Cardiology/American Heart Association clinical practice guidelines that advocate OMT as an appropriate initial management strategy, regardless of age. (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COURAGE]; NCT00007657 [ClinicalTrials.gov] )

Key Words: percutaneous coronary intervention • optimal medical therapy • coronary artery disease

Abbreviations and Acronyms
  ACC = American College of Cardiology
  ACS = acute coronary syndromes
  AHA = American Heart Association
  BMI = body mass index
  CAD = coronary artery disease
  MI = myocardial infarction
  OMT = optimal medical therapy
  PCI = percutaneous coronary intervention


Related Article

Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A26. [Full Text] [PDF]





 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement